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Natural killer (NK) cells belong to the innate immune system and are key effectors in the
immune response against cancer and infection. Recent studies have contributed to the
knowledge of events controlling NK cell fate. The use of knockout mice has enabled the
discovery of key transcription factors (TFs) essential for NK cell development and function.
Yet, unwrapping the downstream targets of these TFs and their inﬂuence on NK cells
remains a challenge. In this review, we discuss the latest TFs described to be involved in
the regulation of NK cell development and maturation.
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INTRODUCTION
Natural killer (NK) cells are innate immune lymphocytes that
play an important role in the immune response against tumors
and infection by either mediating direct cell lysis or by pro-
ducing a plethora of cytokines (Trinchieri, 1989). The bone
marrow (BM) is considered to be the main site of NK cell
development, however, it has been reported that NK cell devel-
opment and maturation can take place in other sites such as
the thymus (Vosshenrich et al., 2006) and lymph nodes (LNs;
Freud et al., 2005, 2006). NK cell development occurs in dif-
ferent stages, CD34+ hematopoietic stem cells differentiate into
common lymphoid progenitors that can give rise to NK cell pre-
cursors that then develop into immature NK cells. Finally, the
maturation of immature NK cells into fully functional NK cells
involves the acquisition of activating and inhibitory receptors
that regulate NK cell effector functions (Lanier, 2005). NK cell
development has been the subject of many studies, major con-
tributions have been made during the last decade and several
pathways of NK cell development have emerged, however, our
understanding of how these developmental stages are regulated
on a molecular level is still relatively limited in mice and even
more so in humans (Hesslein and Lanier, 2011; Martin-Fontecha
et al., 2011).
Transcription factors (TFs) are key molecules in the regula-
tion of gene transcription and have a great inﬂuence on immune
cell fate and differentiation. Knockout mice have allowed the
identiﬁcation of several TFs involved in the commitment to the
NK cell lineage, in the regulation of NK cell maturation or
of tissue-speciﬁc NK cells. This review summarizes the latest
information on the role of TFs in the regulation of NK cell devel-
opment, maturation, and function in both mice (Figure 1) and
humans.
TRANSCRIPTION FACTORS INVOLVED IN THE REGULATION
OF NK CELL DEVELOPMENT
E4BP4
E4-binding protein 4 (E4BP4), also called nuclear factor
interleukin-3 (NFIL3), is a basic leucine zipper TF shown to
regulate a broad range of mechanisms such as the mammalian
circadian clock (Mitsui et al., 2001) and IL-3-dependent survival
of pro-B cells (Ikushima et al., 1997) to name some. Using mice
deﬁcient for E4bp4, Gascoyne et al. (2009) and Kamizono et al.
(2009) demonstrated that E4bp4 is required for NK cell develop-
ment and maturation. They showed that E4bp4-deﬁcient mice
speciﬁcally lacked mature NK cells, and no other hematopoi-
etic cell lineages, and also had a low number of immature
NK cells, suggesting that E4bp4 is essential for the progres-
sion from NK cell precursors to immature NK cells and then
from immature NK cells to mature NK cells. To note that both
studies also reported that E4bp4-deﬁcient NK cells exhibited
impaired cell cytotoxicity and low IFN-γ production. More-
over, Gascoyne et al. (2009) also demonstrated that E4bp4 acted
downstream of the interleukin 15 receptor (IL-15R) while the
TF Id2 was downstream of E4bp4. These studies identiﬁed for
the ﬁrst time a gene that speciﬁcally determined the NK cell
lineage.
ID TRANSCRIPTION FACTORS
Helix-loop-helix TFs of the Id family are important regulators
of cellular differentiation. Id proteins are transcriptional repres-
sors that antagonize E proteins activity by binding to these
proteins, which in turn are unable to associate with E box
sequences in DNA (Sun et al., 1991). E proteins are TFs that
can either form homodimers and act as transcription activators
or form heterodimers with some basic helix-loop-helix proteins
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FIGURE 1 |Transcription factors involved in the regulation of murine
NK cell development and maturation.The study of TFs in mice has given
valuable information about the molecular regulation of NK cell development.
TFs like E4bp4 and Pu.1 act early promoting NK cell lineage commitment.
Then, several TFs such as E4bp4, Id2, Klf4, andT-bet ensure the transition
from immature to mature NK cells. A complex network ofTFs act downstream
or upstream of theseTFs and others regulating the acquisition of receptors
and NK cell function. Finally, some of theTFs like Gata-3, Klf4, T-bet, andTox
have been shown to be important for the regulation of tissue-speciﬁc
NK cells.
and then act as transcription activators or repressors (Kee, 2009).
E proteins are able to bind the Id family proteins Id1–4. In addition,
others targets than E proteins have been suggested for Id2 such as
the retinoblastoma protein (Iavarone et al., 1994) but E proteins
are their main binding partners.
It is known since the late 1990s that Id proteins are essen-
tial for NK cell development and maturation. Mice deﬁcient
for Id2 have been shown to lack LNs, Peyer’s patches as well
as to have reduced number of mature NK cells in the spleen
(Yokota et al., 1999). Furthermore, it was reported that the
overexpression of Id3 in CD34 progenitors was able to inhibit
T cell development and to favor the generation of NK cells
(Heemskerk et al., 1997). The role of Id2 in the regulation of
NK cell development was conﬁrmed by another study from Boos
et al. (2007), although the role of Id2 seems to be essential at
a later stage in differentiation. They reported that Id2−/− mice
have low number of mature NK cells in the periphery while
having normal number of immature NK cells and NK cell pre-
cursors in the BM highlighting the importance of Id2 for the
maturation of immature NK cells. The phenotype observed in
Id2−/− animals was linked to the capacity of Id2 to inhibit E2A
proteins.
TRANSCRIPTION FACTORS INVOLVED IN THE REGULATION
OF NK CELL MATURATION AND FUNCTION
BLIMP1
BLIMP1, also known as PRMD1 or PRDI-BF1, is a transcriptional
repressor crucial for the terminal differentiation of plasma cells
and CD8+ effector T cells. Mouse NK cells all express one isoform
of Blimp1 (Kallies et al., 2011). Blimp1 expression is induced by
IL-15 during differentiation but can be upregulated by cytokines
during maturation, the most mature NK cells expressing the high-
est level of BLIMP1 inbothhumans andmice. BLIMP1 is necessary
for NK cell peripheral maturation and homeostasis but is not
required to obtain normal number of NK cells in mice. While
IRF4 and Bcl6 regulate Blimp1 expression in B and T cells, it has
been shown that T-bet acts upstream of Blimp1 in mouse NK
cells. Finally, cytokine production and cytotoxicity is not altered
in Blimp1-deﬁcient NK cells, however, Blimp1 was essential for
high granzyme B expression in NK cells.
Human NK cells, in particular CD56dim NK cells, express
three distinct isoforms of BLIMP1 (α, β, and a splice variant)
upon activation (Kallies et al., 2011), BLIMP1β being the pre-
dominant isoform present in human NK cells. Whereas BLIMP1
did not seem to be essential for the regulation of NK cell
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function in mice, BLIMP1 negatively regulate the production
of IFN-γ, TNF-α, and TNF-β in human NK cells highlighting
a differential role of BLIMP1 in mouse and human NK cells.
As for mouse NK cells, BLIMP1 does not affect human NK cell
cytotoxicity.
EOMES
In vertebrates, as for T-bet, Eomesodermin (Eomes) belongs to the
T-box family of TFs and plays an important role in the initiation
of mesodermal differentiation and in determining cell fate (Ryan
et al., 1996). In addition, Eomes has been reported to be a key
factor controlling CD8+ T cell lytic function (Pearce et al., 2003)
by regulating granzyme B and perforin expression (Sullivan et al.,
2003). In mice, Eomes is essential for NK cell maturation and it
has been shown that Eomes is necessary to maintain the mature
attributes of NK cells (Gordon et al., 2012).
Gill et al. (2012) in an effort to elucidate the mechanisms of
NK cell exhaustion after adoptive transfer, discovered that T-bet
and Eomes are rapidly downregulated in NK cells upon transfer
in tumor bearing mice. There was an inverse correlation between
NK cell proliferation and IFN-γ production and the expression of
these TFs. Overexpression of Eomes, not T-bet, resulted in tumor
burden reduction (Gill et al., 2012) and Eomes expression was not
affected by T-bet expression (Townsend et al., 2004).
Finally, thework byGordon et al. (2012) suggests that T-bet and
Eomes regulate two sequential checkpoints of NK cell maturation.
Additional research will help to clarify the role of these TFs, since
other authors suggest that adoptive transfer experiments did not
provide sufﬁcient evidence that T-bet and Eomes act sequentially
on NK cell maturation (Jiang et al., 2012).
ETS-1
ETS-1 belongs to the Ets family of winged helix-turn-helix TFs.
While Elf-1, another TFs of the Ets family, is not required for NK
cell development (Choi et al., 2011), it has been known for more
than a decade than Ets-1-deﬁcient mice have a reduced number
of NK cells notably in the spleen and BM (Barton et al., 1998),
however, the exact function of Ets-1 in NK cells and when Ets-1
is important for NK cell development has only been discovered
recently.
Natural killer cell development and NK cell function are
severely impaired in Ets-1-deﬁcient mice. It has been shown
that Ets-1 is a key TFs very early during NK cell develop-
ment in particular to induce the expression of other TFs also
involved in the regulation of NK cell development such as T-bet
and Id2 (Ramirez et al., 2012). Moreover, Ets-1 is also essen-
tial for the expression of key receptors that regulate NK cell
activity such as NKp46, Ly49H, and Ly49D in mice. Barton
et al. (1998) reported that Ets-1-deﬁcient NK cells were poorly
cytolytic and were not able to kill YAC1 cells. Ramirez et al.
(2012) report that NK cells deﬁcient for Ets-1 are not able to
degranulate after stimulation and express lower levels of NK
cell receptors, which could explain Ets-1-deﬁcient NK cell low
cytotoxic activity. However, Ets-1-deﬁcient NK cells were hyper-
responsive to cytokines such as IL-15 and exhibited characteristics
of chronic activation such as increased expression of inhibitory
receptors.
GATA-3
GATA-3 is a TF that plays an important role in T cell development
and T cell differentiation (Ting et al., 1996; Zheng and Flavell,
1997). Even though the number of NKcells was reported to be nor-
mal in the spleen of Gata-3-deﬁcient mice (Samson et al., 2003),
NK cells in these mice were actually immature suggesting a role for
Gata-3 in NK cell maturation but not in NK cell speciﬁcation. NK
cell cytotoxicity was not affected in the absence of Gata-3, how-
ever,Gata-3-deﬁcientNKcells produced less IFN-γ thanwild-type
(WT) mice. This study also showed that Gata-3 was important for
NK cell response to Listeria monocytogenes infection. Moreover,
Gata-3 was demonstrated to be involved in the regulation of NK
cell homeostasis as the number of NK cells was drastically reduced
in the liver of Gata-3−/− mice. Finally, Vosshenrich et al. (2006)
reported that although Gata-3 was dispensable for the develop-
ment of NK cells in the BM it was indispensable for the generation
of CD127+ thymic NK cells.
HELIOS
Helios is a member of the Ikaros family of TFs. The role of this TFs
has been studied mainly in regulatory T cells (Getnet et al., 2010)
and lymphoid malignancies (Rebollo and Schmitt, 2003). It has
been shown that Helios can be induced during T cell activation
and proliferation (Akimova et al., 2011).
Using themicemodelNoe,Narni-Mancinelli et al. (2012) found
that the absence of NKp46 expression made NK cells hyperactive.
The study of the transcriptome of WT mice revealed the increased
expression of the TF Helios in the mature CD11b+ NK cell sub-
set expressing NKp46. In Noe mice, Helios transcripts were twice
as abundant in the CD11b+ NK cells as compared to the same
subset in WT mice. Silencing of Helios in NK cells isolated from
Noe mice restored their reactivity to the level observed for WT NK
cells. The authors suggest that Helios downregulation is involved
in the regulation of NK cell reactivity via NKp46 (Narni-
Mancinelli et al., 2012).
KLF4
Krüppel-like factor 4 (KLF4) is a TF key in the regulation of
stem cell pluripotency. Klf4 is a downstream target of Pu.1 and
is an important TF that determines the progenitor cell fate of
different immune cells such as NK cells. Using inducible and
lineage-speciﬁc Cre transgenic mice, it was reported that the
loss of Klf4 resulted in low numbers of NK cells in the blood
and in the spleen but normal numbers in other organs such
as the BM, liver, and LNs (Park et al., 2012). These mice also
exhibited increased apoptosis of NK cells in the spleen but the
remaining NK cells were fully functional. This defect was not
intrinsic as adoptive transfer of Klf4-deﬁcient NK cells in WT
mice shows recovery of the phenotype. As the number of con-
ventional dendritic cells was lower in the spleen of Klf4-deﬁcient
animals it was suggested that Klf4 is essential for dendritic cell
maintenance in the spleen promoting NK cell survival in that
organ.
T-bet
T-bet (Tbx21) belongs to the T-box family of TFs, involved in
the early cell fate decision, cell differentiation, and organogenesis
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(Wilson and Conlon, 2002). Knockout mice have given valuable
insight into the role of this TF in the regulation of immune cells.
T-bet was ﬁrst described as an initiator of T helper (Th)1 lineage
development, redirecting Th2 and Tc2 primary T cells into the
Th1 lineage, controlling the generation of CD8+ cytotoxic effector
cells, and the expression of IFN-γ into those cells (Szabo et al.,
2000; Sullivan et al., 2003).
Moreover, T-bet-deﬁcient mice exhibited a reduced number of
NK cells in the spleen, liver, and peripheral blood (Townsend
et al., 2004). T-bet−/− NK cells showed a high expression of
cKit and αv integrin, markers of immature NK cells. The detec-
tion of high levels of CD69 suggested an activated state of these
NK cells. In addition, these hyperactivated cells underwent aug-
mented spontaneous apoptosis. Finally, T-bet−/− NKcells showed
impaired cytotoxicity and IFN-γproduction in response tomurine
cytomegalovirus highlighting a critical role for T-bet in the control
of NK cell maturation (Townsend et al., 2004).
The proximal promoters of T-BET contain two Ets binding
sites that are highly conserved. ETS TFs such as MEF, PU.1, and
ETS1 can probably regulate the expression of T-BET during the
last NK cell development stages (Townsend et al., 2004). It has also
been suggested that T-BET expression can be regulated by GATA-3
(Samson et al., 2003) and indirectly by TOX (Yun et al., 2011).
In addition, it has been suggested that T-bet expression in NK
cells is important for the control of metastatic disease (Werneck
et al., 2008) and the crosstalk between the innate and adaptive
immunity. In this study, T-bet−/− NK cells had reduced longevity
in vivo when compared to WT NK cells, their apoptotic pheno-
type and impaired effector function, low IFN-γ secretion and low
killing in vitro, correlated with the susceptibility of T-bet−/− mice
to develop melanoma metastasis.
Furthermore, T-bet regulates the expression of sphingosine-1
phosphate receptor 5 (S1P5) that plays an important role inNKcell
recirculation (Walzer et al., 2007). Duane, a mouse strain with a
FIGURE 2 | Role ofT-bet in NK cell development and function
in mice. (A)T-bet-deﬁcient mice have low NK cell numbers in the spleen,
liver, and peripheral blood with accumulation of NK cells in LNs and BM.
(B) NK cells fromT-bet-deﬁcient mice have an immature phenotype,
expression of αv integrin and ckit, and high levels of CD69. T-bet−/−
NK cells undergo rapid apoptosis and have decreased longevity in
addition to impaired cytotoxicity and low IFN-γ production. (C) Different
TFs regulate T-bet, among these, Ets-1, Gata-3, Mef, and Pu.1. T-bet
represses CD27 expression in mature NK cells and negatively
regulates S1P5.
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point mutation in T-bet, has a decreased number of circulating
and spleen NK cells. Duane mice have an altered NK cell trafﬁck-
ing, with NK cell accumulation in LNs and BM (Jenne et al., 2009),
identifying T-bet driven S1P5 expression to be essential for NK cell
egress from LNs and BM.
Finally, Gordon et al. (2012) noticed the absence of the imma-
ture population expressing the death receptor TRAIL (TRAIL+
DX−), found normally in the liver of WT mice. When T-bet
was temporarily deleted ex vivo in hepatic NK cells and trans-
ferred to immunodeﬁcient mice, only TRAIL− NK cells were
found. This suggests that T-bet plays a role in the maintenance
of the TRAIL+ subset (Gordon et al., 2012). In mice, NK cells
undergo four development stages according to the expression of
CD11b and CD27 (CD11blowCD27low → CD11blowCD27high →
CD11bhighCD27high → CD11bhighCD27low; Chiossone et al.,
2009). Gordon et al. (2012) proposed that T-bet is necessary for
CD27 repression among mature NK cells. The authors found
that this repression was cell intrinsic, contrary to Soderquest et al.
(2011), that suggest that the transition from CD11bhighCD27high
to CD11bhighCD27low could also be partially extrinsic as the
expression of T-bet and IL-15Rα on monocytes is determinant
to allow NK cells to proceed to the ﬁnal differentiation stage.
Altogether, the recent research suggests that T-bet is a key fac-
tor that controls NK cell maturation and cytokine, perforin, and
granzyme B production in NK cells. In addition, T-bet controls
NK cell homeostasis and, in particular, affects SP15 dependent NK
cell migration (Figure 2). T-bet targeting could have an impact
on NK cell immunotherapy in the future, and elucidating the
molecular pathways of NK cell development may reveal additional
targets.
TOX
The thymocyte selection-associated HMG box factor (TOX) is a
DNA-binding factor essential for T cell development (Aliahmad
and Kaye, 2008). Tox has been shown to be expressed in thymo-
cytes undergoing positive selection (Wilkinson et al., 2002) and
essential for CD4 T cell development including regulatory T cells
as well NKT cells but not for CD8 T cell or B cell development
(Wilkinson et al., 2002; Aliahmad et al., 2004, 2011; Aliahmad and
Kaye, 2008).
Interestingly, Tox−/− mice have a similar phenotype to
Ikaros−/− and Id2−/− mice, and lack mature NK cells in the
periphery as well as LNs (Aliahmad et al., 2010). This study also
highlights the fact that Id2 and Tox are important in the regulation
of NK cell developmental stages onward to NK cell precursors and
that another regulation pathway other than Tox and Id2 is required
for the regulationof NKcell development. In addition, Toxhas also
been shown to regulateNK cell differentiation fromhematopoietic
stem cells in vitro (Yun et al., 2011).
CONCLUDING REMARKS
Natural killer cell development in humans and mice has been
widely studied for several decades. Yet, dismantling the regula-
tion of the events that control NK cell development remains a
challenge. The use of knockout mice and technology that allows
the silencing of speciﬁc genes has given us a better understanding
of the function and importance of TFs in NK cell development
and maturation. Gaining insight into the regulation of NK cell
development will unveil better strategies for NK cell systems that
can be used in immunotherapy in addition to a better com-
prehension of the mechanisms regulating NK cells for targeted
therapies.
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